who owns the patent for semaglutide Ozempic, Wegovy and Rybelsus: patents behind Novo Nordisk's weight-loss drugs Semaglutide: Just Another Off-Patent Generic?

If the ED medicine is unsuitable in certain cases, alternatives such as VEDs, penile implants, or intraurethral suppositories can help manage ED effectively

According to Novo Nordisk, acute gallstone disease was reported in 1.6 per cent of patients, which led to cholecystitis - or inflammation of the gallbladder - in 0.6 per cent of patients

doi:10.1038/ja.2017.62

Brand-name pen devices (Mounjaro/Zepbound): Unopened pens can remain at room temperature up to 86 degrees Fahrenheit (30 degrees Celsius) for up to 21 days

doi: 10.1016/j.cmet.2015.03.001

Long-awaited glucagon-like peptide-1 agonist (GLP-1) tablets dont appear to be stealing significant market share from GLP-1 injectables